{"id":50842,"date":"2014-03-03T20:12:20","date_gmt":"2014-03-03T20:12:20","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=50842"},"modified":"2022-12-02T12:13:02","modified_gmt":"2022-12-02T17:13:02","slug":"national-drug-screening","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/national-drug-screening\/","title":{"rendered":"National Drug Screening"},"content":{"rendered":"\n

Company Description<\/strong><\/p>\n\n\n\n

Providing back-office TPA services for TPA\u2019s, we fulfill an industry need for a state of the art technology software platform combined with Medical Review Officer (MRO) services<\/strong><\/a>, drug testing<\/a>, training, and consultation<\/a><\/strong>. NDS will offer one system for scheduling, ordering, resulting and processing paperless drug testing: lab and POCT.<\/p>\n\n\n\n

A fast-growing company selling drug testing services to individuals and employers in all areas of the United States.  Our headquarters in Melbourne, Florida coordinates all sales functions and customer service for our clients.  Our strength in our industry is our dedication to excellence in customer service and the efficient use of the latest technology.  Our mission includes:  1. Reaching annual monetary goals for sustainability and profitability 2. Providing great customer experience & service 3. Retaining status as top industry experts and 4. Providing for our team members a great place to work.<\/p>\n","protected":false},"excerpt":{"rendered":"

Company Description Providing back-office TPA services for TPA\u2019s, we fulfill an industry need for a state of the art technology software platform combined with Medical Review Officer (MRO) services, drug testing, training, and consultation. NDS will offer one system for scheduling, ordering, resulting and processing paperless drug testing: lab and POCT. A fast-growing company selling […]<\/p>\n","protected":false},"author":12,"featured_media":424,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"50858,50870,50935,51391,50862,51390","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50842"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=50842"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50842\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/424"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=50842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=50842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=50842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}